Elk Grove Village is a village in Cook and DuPage counties in the U.S. state of Illinois. Per the 2020 census, the population was 32,812. Located 20 miles northwest of Chicago along the Golden Corridor, the Village of Elk Grove Village was incorporated on July 17, 1956.

During the past decade, Elk Grove Village, Illinois conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Elk Grove Village, Illinois" are "Parkinson Disease" (2 trials) and "Apathy in Dementia" (1 trials). Many other conditions were trialed in "Elk Grove Village, Illinois" in a lesser frequency.

Most popular intervention types in "Elk Grove Village, Illinois" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Tavapadon" (2 trials), "CVL-871 1.0 mg" (1 trials) and "CVL-871 3.0 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elk Grove Village, Illinois" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Elk Grove Village, Illinois". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Elk Grove Village, Illinois, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Elk Grove Village, Illinois, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".